MedPath

Randomised controlled trial of surveillance and no surveillance for patients with Barrett's oesophagus

Not Applicable
Completed
Conditions
Barrett's oesophagus
Digestive System
Registration Number
ISRCTN54190466
Lead Sponsor
Gloucestershire Royal NHS Foundation Trust (UK)
Brief Summary

2015 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/25767103 protocol

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
3520
Inclusion Criteria

Patients over 18 with endoscopic and histologically proven barrett's oesophagus greater than 1 cm

Exclusion Criteria

1. Unable to give consent
2. Unable to tolerate upper gastrointestinal endoscopy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. All causes mortality<br>2. Death from adenocarcinoma<br>3. Development of treatable adenocarcinoma <br>Duration of follow-up: 10 years
Secondary Outcome Measures
NameTimeMethod
1. Quality of life: Reflux Questionnaire and EQ50 Quality of Life Questionnaire at yearly intervals by post<br>2. Cost effectiveness of endoscopy
© Copyright 2025. All Rights Reserved by MedPath